CytRx (CYTR) and Cephalon (CEPH) Oncology Therapies to be Evaluated as Treatment for Relapsed Acute Promyelocytic Leukemia
Tweet Send to a Friend
CytRx Corporation (NASDAQ: CYTR) announced the initiation of a dose escalation study with its oncology drug candidate tamibarotene combined with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
